Cargando…

Protocol and statistical analysis plan for the REstricted fluid therapy VERsus Standard trEatment in Acute Kidney Injury—REVERSE‐AKI randomized controlled pilot trial

BACKGROUND: Fluid accumulation frequently coexists with acute kidney injury (AKI) and is associated with increased risk for AKI progression and mortality. Among septic shock patients, restricted use of resuscitation fluid has been reported to reduce the risk of worsening of AKI. Restrictive fluid th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaara, Suvi T., Ostermann, Marlies, Selander, Tuomas, Bitker, Laurent, Schneider, Antoine, Poli, Elettra, Hoste, Eric, Joannidis, Michael, Zarbock, Alexander, van Haren, Frank, Prowle, John, Pettilä, Ville, Bellomo, Rinaldo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Special Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384021/ https://www.ncbi.nlm.nih.gov/pubmed/32022904 http://dx.doi.org/10.1111/aas.13557

Ejemplares similares

Restrictive fluid management versus usual care in acute kidney injury (REVERSE-AKI): a pilot randomized controlled feasibility trial
por: Vaara, Suvi T., et al.
Publicado: (2021)

Report of the first AKI Round Table meeting: an initiative of the ESICM AKI Section
por: Ostermann, M., et al.
Publicado: (2019)

Urine NGAL as a biomarker for septic AKI: a critical appraisal of clinical utility—data from the observational FINNAKI study
por: Törnblom, Sanna, et al.
Publicado: (2020)

Fluid balance‐adjusted creatinine in diagnosing acute kidney injury in the critically ill
por: Törnblom, Sanna, et al.
Publicado: (2021)

Predicting one-year mortality of critically ill patients with early acute kidney injury: data from the prospective multicenter FINNAKI study
por: Poukkanen, Meri, et al.
Publicado: (2015)

Noninterventional follow‐up vs fluid bolus in RESPONSE to oliguria—The RESPONSE trial protocol and statistical analysis plan
por: Inkinen, Nina, et al.
Publicado: (2020)

Non-interventional follow-up versus fluid bolus in RESPONSE to oliguria in hemodynamically stable critically ill patients: a randomized controlled pilot trial
por: Inkinen, Nina, et al.
Publicado: (2022)

Fluid balance and renal replacement therapy initiation strategy: a secondary analysis of the STARRT-AKI trial
por: Wald, Ron, et al.
Publicado: (2022)

The AKI care bundle: all bundle components are created equal—are they?
por: von Groote, Thilo C., et al.
Publicado: (2021)

Correlation between the AKI classification and outcome
por: Ostermann, Marlies, et al.
Publicado: (2008)

Different applications of the KDIGO criteria for AKI lead to different incidences in critically ill patients: a post hoc analysis from the prospective observational SICS-II study
por: Wiersema, Renske, et al.
Publicado: (2020)

Urinary cell cycle arrest biomarkers and chitinase 3-like protein 1 (CHI3L1) to detect acute kidney injury in the critically ill: a post hoc laboratory analysis on the FINNAKI cohort
por: Hoste, Eric A., et al.
Publicado: (2020)

Generic outcome set for the international registry on Laser trEAtments in Dermatology (LEAD): a protocol for a Delphi study to achieve consensus on what to measure
por: Fransen, Frederike, et al.
Publicado: (2020)

Acute kidney injury in the critically ill: an updated review on pathophysiology and management
por: Pickkers, Peter, et al.
Publicado: (2021)

Population-based incidence, mortality and quality of life in critically ill patients treated with renal replacement therapy: a nationwide retrospective cohort study in finnish intensive care units
por: Vaara, Suvi T, et al.
Publicado: (2012)

Cardiac Surgery Associated AKI Prevention Strategies and Medical Treatment for CSA-AKI
por: Ostermann, Marlies, et al.
Publicado: (2021)

Management of extra-articular fractures of the fifth metacarpal: Operative vs. Non-opeRaTive TrEatment (FORTE) – A systematic review and meta-analysis()
por: Wormald, JCR, et al.
Publicado: (2019)

Common Inflammation-Related Candidate Gene Variants and Acute Kidney Injury in 2647 Critically Ill Finnish Patients
por: Vilander, Laura M., et al.
Publicado: (2019)

Genetic variants in SERPINA4 and SERPINA5, but not BCL2 and SIK3 are associated with acute kidney injury in critically ill patients with septic shock
por: Vilander, Laura M., et al.
Publicado: (2017)

A drug-eluting Balloon for the trEatment of coronarY bifurcatiON lesions in the side branch: a prospective multicenter ranDomized (BEYOND) clinical trial in China
por: Jing, Quan-Min, et al.
Publicado: (2020)

A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial
por: Zampieri, Fernando G., et al.
Publicado: (2022)

Age of red blood cells and outcome in acute kidney injury
por: Kaukonen, Kirsi-Maija, et al.
Publicado: (2013)

Heparin-binding protein (HBP) improves prediction of sepsis-related acute kidney injury
por: Tverring, Jonas, et al.
Publicado: (2017)

Urinary Biomarkers Indicative of Apoptosis and Acute Kidney Injury in the Critically Ill
por: Vaara, Suvi T., et al.
Publicado: (2016)

Early prolonged neutrophil activation in critically ill patients with sepsis
por: Törnblom, Sanna, et al.
Publicado: (2021)

Heme oxygenase-1 repeat polymorphism in septic acute kidney injury
por: Vilander, Laura M., et al.
Publicado: (2019)

Renal recovery after acute kidney injury
por: Forni, L. G., et al.
Publicado: (2017)

Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study
por: Mildh, Henriikka, et al.
Publicado: (2016)

Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine
por: Joannidis, M., et al.
Publicado: (2017)

Acute kidney injury 2016: diagnosis and diagnostic workup
por: Ostermann, Marlies, et al.
Publicado: (2016)

Fluid accumulation increases the risk of AKI progression and death in critically ill patients with early AKI
por: Raimundo, MR, et al.
Publicado: (2014)

Soluble CD73 in Critically Ill Septic Patients – Data from the Prospective FINNAKI Study
por: Vaara, Suvi T., et al.
Publicado: (2016)

1338. A Pooled Analysis of Patients With Wound Infections in the Phase 3 REVIVE Trials: Randomized, Double-blind Studies to EValuate the Safety and Efficacy of Iclaprim Vs. Vancomycin for trEatment of Acute Bacterial Skin and Skin Structure Infections
por: Huang, David, et al.
Publicado: (2018)

Association of endothelial and glycocalyx injury biomarkers with fluid administration, development of acute kidney injury, and 90-day mortality: data from the FINNAKI observational study
por: Inkinen, Nina, et al.
Publicado: (2019)

Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injury
por: Pickkers, Peter, et al.
Publicado: (2023)

Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial
por: Meersch, Melanie, et al.
Publicado: (2017)

Two subphenotypes of septic acute kidney injury are associated with different 90-day mortality and renal recovery
por: Wiersema, Renske, et al.
Publicado: (2020)

Variation in severity-adjusted resource use and outcome in intensive care units
por: Takala, Jukka, et al.
Publicado: (2021)

AKI patients have worse long-term outcomes, especially in the immediate post-ICU period
por: Hoste, Eric AJ, et al.
Publicado: (2012)

Clearance of inflammatory cytokines in patients with septic acute kidney injury during renal replacement therapy using the EMiC2 filter (Clic-AKI study)
por: Lumlertgul, Nuttha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iq7l05vec9p8jfiuabrd2ma24m